Associated Papers
Targeted modification of cis-elements in the CUL3 gene to restore exon 9 inclusion for treating Gordon syndrome.
Shi X et al.
Human Genomics, 2025
Insights into the diverse mechanisms and effects of variant CUL3-induced familial hyperkalemic hypertension.
Sharma P et al.
Cell Communication and Signaling : Ccs, 2023
Double synonymous mutations in exon 9 of the Cullin3 gene restore exon inclusion by abolishing hnRNPs inhibition.
Liu Z et al.
Human Molecular Genetics, 2022
The variety of genetic defects explains the phenotypic heterogeneity of Familial Hyperkalemic Hypertension.
Hureaux M et al.
Kidney International Reports, 2021
34622103 (PubMed )
Supplement: mmc1.pdf
Familial cases of pseudohypoaldosteronism type II harboring a novel mutation in the Cullin 3 gene.
Nakano K et al.
Nephrology (carlton, Vic.), 2020
Familial Hyperkalemic Hypertension Genotype With a Negative Phenotype: A CUL3 Mosaicism.
Ostrosky-Frid M et al.
American Journal of Hypertension, 2020
A novel mutation in exon 9 of Cullin 3 gene contributes to aberrant splicing in pseudohypoaldosteronism type II.
Shao L et al.
Febs Open Bio, 2018
Select a paper to view details